The Prostate Imaging Reporting and Data System (PI-RADS) version 2 (v2) categorizes the likelihood of clinically significant prostate cancer (csPCa) on magnetic resonance imaging (MRI) and determines the diagnostic pathway.
The Prostate Imaging Reporting and Data System (PI-RADS) version 2 (v2) categorizes the likelihood of clinically significant prostate cancer (csPCa) on magnetic resonance imaging (MRI) and determines the diagnostic pathway.